echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > WPMCS2020 . . . These pundits will deliver keynote presentations at the 5th Global Precision Medicine (China) Summit!

    WPMCS2020 . . . These pundits will deliver keynote presentations at the 5th Global Precision Medicine (China) Summit!

    • Last Update: 2020-09-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Guide: Authoritative scholars come to the Global Precision Medicine (China) Summit, which will set sail on the same day.
    . Since the first Global Precision Medicine (China) Summit was held in 2016, the Conference has consistently maintained the size of thousands of people, including precision diagnosis, tumor precision treatment, cell therapy, precision medicine and many other hot topics, inviting relevant experts from different angles to share, including Wang Hongyang, Chen Runsheng, Yu Jia, Ji Jiafu, Professor Yu Jun, Director Li Jin and other authoritative speaker in this field.
    the 5th Global Precision Medicine (China) Summit on November 26-28, 2020 will set sail again in Shanghai! Meeting Time: November 26-28, 2020 Venue: Shanghai Sanjiagang Greenfield International Conference Center Conference Size: 1500 People Conference Official Website: Agenda Overview Speaker Wang Hongyang, Chinese Academy of Engineering, Director of the National Center for Liver Cancer Science, Director of the Center for International Cooperation biosport transductive Research Xie Xiaoliang, Fellow of the National Academy of Sciences, Foreign Fellow of the Chinese Academy of Sciences, Director of the Center for Biomedical Frontier Innovation, Peking University, Director of the Center for Future Genetic Diagnostic Excellence innovation in Beijing Zhao Chunhua, Fellow of the French Academy of European Sciences, Director of the Organizational Engineering Research Center of the Chinese Academy of Medical Sciences, Director of the Department of Cell Biology of the Institute of Basic Medicine of the Chinese Academy of Medical Sciences, Director of the Department of Cell Biology of the Chinese Academy of Medical Sciences, Han Zhongchao, Director of the Cell Resource Storage and Research Center of the China Food and Drug Inspection Research Institute, Chairman of the Board of Directors of Beijing Han's United Biotechnology Co., Ltd., Zhu Jun, Member of the French National Academy of Technical Sciences Zhu Jun, Party Secretary of the University of Beijing Cancer Hospital, Director of the Department of Lymphoma, Director of the Department of Lymphoma, Andi. Lu Wei, Vice President of Commercial Development, Shanghai Pharmaceutical Juno Biotech Co., Ltd., Wang Xinxin, CEO of Heyuan Biotech Co., Ltd., Zhang Yong, Head of TruUCAR Research and Development, Shu Dean Pharmaceutical Research and Development (Beijing) Co., Ltd., General Manager of China, Xia Ningjun, Dean of Xiamen University School of Public Health, Director of the National Center for Infectious Disease Diagnostic Reagents and Vaccine Engineering and Technology Research, Liang Jun, Vice President of Peking University International Hospital, Director of the Cancer Center, Director of the Drug Clinical Trials Agency, Director of the Central Hospital of Fudan University Dr., Doctoral Tutor, Professor Yu Hengjun, Director of Shanghai Center for Molecular Medicine Engineering Technology Research, Deputy Director of The Biochip Shanghai National Engineering Research Center, Lu Hongzhou, Director of the National Medical City Bios sample bank and Institute of Translational Medicine, Party Secretary of Fudan University Affiliated Public Health Clinical Center, Assistant Dean of Huashan Hospital affiliated with Fudan University, Director of the Oncology Center of Wuhan University People's Hospital, Director of oncology Department Yu Guiping, Director of the Oncology Branch of Xi'an City, Xi'an 9th Hospital Director of Guangdong Lung Cancer Research Institute, Director of the Central Laboratory Yu Jinpu, Director of the Cancer Molecular Diagnostic Center of Tianjin Cancer Hospital Xiao Yanqun, Director of the Clinical Cell Molecular Genetics Research Office of the Shanghai Clinical Testing Center, Director of the Molecular Pathology Research Office Wang Yuming, Director of the All-Army Infectious Disease Research Institute, Director of the Infection Branch of the Southwest Hospital of the Third Military Medical University, Wang Xuefeng, Experimental Diagnostic Center of Ruijin Hospital affiliated with Shanghai Jiao university Zhou Yuanjun, Director of the Department of Inspection and Clinical Blood Transfusion, Heng Ruiyuan Zheng (Shenzhen) Biotech Co., Ltd. Chief Scientist He Yongjie, Wang Liqun, Chief Medical Officer of Reding Pharmaceuticals, Lu Uyg, CEO of Fosun Kate Biotech Co., Ltd., Zhang Tongsheng, Director of chest Oncology Department, Huaxi Hospital, Sichuan University, Chairman of Wuhan Polida Biotech Co., Ltd. Topics discussing Single-cellGenomicsforMedicine: Scientific Diagnosis and Treatment of NewbornstoSearching Neutralizing AntibodiesagainstCOVID-19 New Coronary Virus Infection CT CS in the field of liquid biopsy clinical application of in-body diagnosis challenges and future vision of the second generation sequencing technology in the precise diagnosis of infection using cfDNA methylation analysis method for cancer trace nucleic acid detection in the rapid detection of infectious diseases advantages and challenges Helicobacter pylrosil resistant strain bank, Molecular diagnostic transformation research and personalized treatment of NGS large Panel in tumor immunotherapy applied research focus on the global vision: cell therapy commercialization strategy and challenge CAR-T clinical progress in lymphoma treatment and the status quo of new CAR-T cell therapy treatment T-cell malignant tumor TruUCAR™ therapy treatment recurrence or recurring T-cell malignancies breakthrough research Parkinson's stem cell clinical research progress stem cell treatment and complications of the future Sweep code completion registration thanks to the following institutions for their strong support for WPMCS2020! Co-organizing agency support agency cooperative media if there is sponsorship / exhibition needs, please contact: Ms. Li: Tel: 180-4970-8695 E-mail: Mavisli@healife.com Ms. Wang Tel: 173-1779-334 Email: sophiawang@healife.com If you have any needs for participation/cooperation, please contact: Ms. Wang: Tel: 177-0174-5462 E-mail: Lynwang@healife.com Related tags: Shanghai, precision medicine, summit sailing 00.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.